These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29949032)

  • 21. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.
    Zhang L; Cao B; Ou R; Wei QQ; Zhao B; Yang J; Wu Y; Shang H
    Parkinsonism Relat Disord; 2017 Feb; 35():63-68. PubMed ID: 27993522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of quality of life in multiple system atrophy and Parkinson's disease].
    Torny F; Lacoste M; Videaud H; Chouly M; Parveau MC; Couratier P
    Rev Neurol (Paris); 2009 Nov; 165(11):911-5. PubMed ID: 19324385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.
    Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).
    Dodel R; Spottke A; Gerhard A; Reuss A; Reinecker S; Schimke N; Trenkwalder C; Sixel-Döring F; Herting B; Kamm C; Gasser T; Sawires M; Geser F; Köllensperger M; Seppi K; Kloss M; Krause M; Daniels C; Deuschl G; Böttger S; Naumann M; Lipp A; Gruber D; Kupsch A; Du Y; Turkheimer F; Brooks DJ; Klockgether T; Poewe W; Wenning G; Schade-Brittinger C; Oertel WH; Eggert K
    Mov Disord; 2010 Jan; 25(1):97-107. PubMed ID: 20014118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urogenital symptoms in Parkinson's disease and multiple system atrophy-Parkinsonism: at onset and later.
    Swaminath PV; Ragothaman M; Koshy S; Sarangmath N; Adhyam M; Subbakrishna DK; Mathias CJ; Muthane UB
    J Assoc Physicians India; 2010 Feb; 58():86-90. PubMed ID: 20653148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of parkinsonism in multiple system atrophy.
    Seppi K; Yekhlef F; Diem A; Luginger Wolf E; Mueller J; Tison F; Quinn NP; Poewe W; Wenning GK
    J Neurol; 2005 Jan; 252(1):91-6. PubMed ID: 15654560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
    Linder J; Stenlund H; Forsgren L
    Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood.
    Balas M; Balash Y; Giladi N; Gurevich T
    J Neural Transm (Vienna); 2010 Mar; 117(3):369-75. PubMed ID: 20091064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease.
    Calandra-Buonaura G; Doria A; Lopane G; Guaraldi P; Capellari S; Martinelli P; Cortelli P; Contin M
    J Neurol; 2016 Feb; 263(2):250-256. PubMed ID: 26566913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red flags for multiple system atrophy.
    Köllensperger M; Geser F; Seppi K; Stampfer-Kountchev M; Sawires M; Scherfler C; Boesch S; Mueller J; Koukouni V; Quinn N; Pellecchia MT; Barone P; Schimke N; Dodel R; Oertel W; Dupont E; Østergaard K; Daniels C; Deuschl G; Gurevich T; Giladi N; Coelho M; Sampaio C; Nilsson C; Widner H; Sorbo FD; Albanese A; Cardozo A; Tolosa E; Abele M; Klockgether T; Kamm C; Gasser T; Djaldetti R; Colosimo C; Meco G; Schrag A; Poewe W; Wenning GK;
    Mov Disord; 2008 Jun; 23(8):1093-9. PubMed ID: 18442131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease.
    Visser M; Verbaan D; van Rooden S; Marinus J; van Hilten J; Stiggelbout A
    Value Health; 2009; 12(2):392-6. PubMed ID: 18657099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of and factors associated with postural deformities in Chinese patients with multiple system atrophy.
    Zhang L; Cao B; Zou Y; Wei QQ; Ou R; Zhao B; Yang J; Wu Y; Shang H
    Parkinsonism Relat Disord; 2019 Jul; 64():324-327. PubMed ID: 30987897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in patients with Parkinson's disease: Implications for falling.
    Gazibara T; Pekmezovic T; Kisic Tepavcevic D; Svetel M; Tomic A; Stankovic I; Kostic VS
    Parkinsonism Relat Disord; 2015 Jun; 21(6):573-6. PubMed ID: 25818536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type.
    Oertel WH; Wächter T; Quinn NP; Ulm G; Brandstädter D
    Mov Disord; 2003 Apr; 18(4):430-2. PubMed ID: 12671951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population.
    Cao B; Guo X; Chen K; Song W; Huang R; Wei QQ; Zhao B; Shang HF
    Neurol Res; 2014 Feb; 36(2):150-6. PubMed ID: 24172715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome.
    Yamamoto T; Asahina M; Yamanaka Y; Uchiyama T; Hirano S; Fuse M; Koga Y; Sakakibara R; Kuwabara S
    J Neurol Sci; 2017 Oct; 381():230-234. PubMed ID: 28991688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.